InsidersTradesSigma
Track the 오가노이드사이언스 stock price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares are quoted on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 오가노이드사이언스 has published 2 public disclosures. Market capitalisation: €52.2bn. The latest transaction was filed on 6 April 2026 (Purchase). Among the most active insiders: 유종만. Every trade is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Organoid Science is a company operating in the health and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative technologies related to organoids.